Loss of pRb2/p130 expression is associated with unfavorable clinical outcome in lung cancer

Clinical Cancer Research

Volumn 8, Issue 12, 2002, Pages 3850-3856

  Caputi, Mario ^a   Groeger, Angela M ^b   Esposito, Vincenzo ^a   De Luca, Antonio ^c   Masciullo, Valeria ^d   Mancini, Alessandro ^a   Baldi, Feliciano ^a   Wolner, Ernst ^a   Giordano, Antonio ^d,e  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

^b UNIVERSITY OF VIENNA   (Austria)

^c REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

^d TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e TEMPLE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FORMALDEHYDE; PARAFFIN; RETINOBLASTOMA PROTEIN; TUMOR MARKER;

ADULT; ANALYTIC METHOD; ARTICLE; CANCER SURVIVAL; CELL LYSATE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE MARKER; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LUNG ADENOCARCINOMA; LUNG CANCER; LUNG SQUAMOUS CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; MULTIGENE FAMILY; MULTIVARIATE ANALYSIS; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN DETERMINATION; PROTEIN EXPRESSION; SURVIVAL TIME; TISSUE SECTION; WESTERN BLOTTING;

EID: 0036898938     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Lee, W. H., Bookstein, R., Hong, F., Young, L. J., Shew, J. Y., and Lee, E. Y. Human retinoblastoma susceptibility gene: Cloning, identification, and sequence. Science (Wash. DC), 235: 1394-1399, 1987.
2. Tonini, T., Hillson, C., and Claudio, P. P. Interview with the retinoblastoma family members: do they help each other? J. Cell. Physiol., 192: 138-150, 2002.
3. Huang, H. J., Yee, J. K., Shew, J. Y., Chen, P. L., Bookstein, R., Friedmann, T., Lee, E. Y., and Lee, W. H. Suppression of the neoplastic phenotype by replacement of the RB gene in human cancer cells. Science (Wash. DC), 242: 1563-1566, 1988.
4. Bookstein, R., Shew, J. Y., Chen, P. L., Scully, P., and Lee, W. H. Suppression of tumorigenicity of human prostate carcinoma cells by replacing a mutated RB gene. Science (Wash. DC), 247: 712-715, 1990.
5. Stiegler, P., and Giordano, A. International Conference on Basic and Clinical Aspects of Cell Cycle Control. J. Cell. Physiol., 185: 485-485, 2000.
6. Masciullo, V., Khalili, K., and Giordano, A. The Rb family of cell cycle regulatory factors: Clinical implications. Int. J. Oncol., 17: 897-902, 2000.
7. Hiebert, S. W., Chellappan, S. P., Horowitz, J. M., and Nevins, J. R. The interaction of RB with E2F coincides with an inhibition of the transcriptional activity of E2F. Genes Dev., 6: 177-185, 1992.
8. Chen, P. L., Scully, P., Shew, J. Y., Wang, J. Y., and Lee, W. H. Phosphorylation of the retinoblastoma gene product is modulated during the cell cycle and cellular differentiation. Cell, 58: 1193-1198, 1989.
9. DeCaprio, J. A., Furukawa, Y., Ajchenbaum, F., Griffin, J. D., and Livingston, D. M. The retinoblastoma-susceptibility gene product becomes phosphorylated in multiple stages during cell cycle entry and progression. Proc. Natl. Acad. Sci. USA, 89: 1795-1798, 1992.
10. DeCaprio, J. A., Ludlow, J. W., Figge, J., Shew, J. Y., Huang, C. M., Lee, W. H., Marsilio, E., Paucha, E., and Livingston, D. M. SV40 Large Tumor Antigen forms a specific complex with the product of the retinoblastoma susceptibility gene. Cell, 54: 275-283, 1988.
11. Dyson, N., Howley, P. M., Munger, K., and Harlow, E. The human Papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science (Wash. DC), 243: 934-937, 1989.
12. Mayol, X., Grana, X., Baldi, A., Sang, N., Hu, Q., and Giordano, A. Cloning of a new member of the retinoblastoma gene family (pRb2) which binds to the E1A transforming domain. Oncogene, 8: 2561-2566, 1993.
13. Huppi, K., Siwarski, D., Mock, B. A., Dosik, J., and Hamel, P. A. Molecular cloning, chromosomal mapping, and expression of the mouse p107 gene. Mamm. Genome, 7: 353-355, 1996.
14. Claudio, P. P., De Luca, A., Howard, C. M., Baldi, A., Firpo, E. J., Koff, A., Paggi, M. G., and Giordano, A. Functional analysis of pRb2/p130 interaction with cyclins. Cancer Res., 56: 2003-2008, 1996.
15. Baldi, A., De Luca, A., Claudio, P. P., Baldi, F., Giordano, G. G., Tommasino, M., Paggi, M. G., and Giordano, A. The Rb2/p130 gene product is a nuclear protein whose phosphorylation is cell cycle regulated. J. Cell Biochem., 59: 402-408, 1995.
16. Cobrinik, D., Whyte, P., Peeper, D. S., Jacks, T., and Weinberg, R. A. Cell cycle-specific association of E2F with the p130 E1 A-binding protein. Genes Dev., 7: 2392-2404, 1993.
17. Hijmans, E. M., Voorhoeve, P. M., Beijersbergen, R. L., van't Veer. L. J., and Bernards, R. E2F-5, a new E2F family member that interacts with p130 in vivo. Mol. Cell. Biol., 15: 3082-3089, 1995.
18. Vairo, G., Livingston, D. M., and Ginsberg, D. Functional interaction between E2F-4 and p130: Evidence for distinct mechanisms underlying growth suppression by different retinoblastoma protein family members. Genes Dev., 9: 869-881, 1995.
19. Cinti, C., and Giordano, A. The retinoblastoma gene family: Its role in cancer onset and progression. Emerging Therapeutic Targets, 4: 765-783, 2000.
20. Zhu, L., van den Heuvel, S., Helin, K., Fattaey, A., Ewen, M., Livingston, D., Dyson, N., and Harlow, E. Inhibition of cell proliferation by 107, a relative of the retinoblastoma protein. Genes Dev., 7: 1111-1125, 1993.
21. Claudio, P. P., Howard, C. M., Baldi, A., De Luca, A., Fu, Y., Condorelli, G., Sun, Y., Colburn, N., Calabretta, B., and Giordano, A. p130/pRb2 has growth suppressive properties similar to yet distinctive from those of retinoblastoma family members pRb and p107. Cancer Res., 54: 5556-5560, 1994.
22. Zhu, L., Enders, G., Lees, J. A., Beijersbergen, R. L, Bernards, R., and Harlow, E. The pRB-related protein p107 contains two growth suppression domains: independent interactions with E2F and cyclin/cdk complexes. EMBO J., 14: 1904-1913, 1995.
23. Yeung, R. S., Bell, D. W., Testa, J. R., Mayol, X., Baldi, A., Grana, X., Klinga-Levan, K., Knudson, A. G., and Giordano, A. The retinoblastoma-related gene. RB2, maps to human chromosome 16q12 and rat chromosome 19. Oncogene, 8: 3465-3468, 1993.
24. Cinti, C., Claudio, P. P., Howard, M. C., Neri, L. M., Fu, Y., Leoncini, L., Tosi, G. M., Maraldi, N. M., and Giordano, A. Genetic alterations disrupting the nuclear localization of the retinoblastomarelated gene Rb2/p130 in human tumor cell lines and primary tumors. Cancer Res., 60: 383-389, 2000.
25. Baldi, A., Esposito, V., De Luca, A., Howard, C. M., Mazzarella, G., Baldi, F., Caputi, M., and Giordano, A. Differential expression of the retinoblastoma gene family members. Rb/p105, p107, Rb2/p130 in lung cancer. Clin. Cancer Res., 2: 1239-1245, 1996.
26. Baldi, A., Esposito, V., De Luca, A., Fu, Y., Meoli, I., Giordano, G. G., Caputi, M., Baldi, F., and Giordano, A. Differential expression of Rb2/p130 and p107 in normal human tissues and in primary lung cancer. Clin. Cancer Res., 3: 1691-1697, 1997.
27. Claudio, P. P., Caputi, M., and Giordano, A. The Rb2/p130 gene: The latest weapon in the war against lung cancer? Clin. Cancer Res., 6: 754-764, 2000.
28. Histological Typing of Lung Tumors, 2nd Ed., pp. 25-26. Geneva: WHO, 1981.
29. Beahrs, O. H., Henson, D. E., Hutter, R. V. P., Kennedy, B. J. (eds.). Lung. Manual for Staging of Cancer. 4th Ed., pp. 115-122. Chicago: American Joint Committee on Cancer, 1992.
30. Susini, T., Baldi, F., Howard, C. M., Baldi, A., Taddei, G., Massi, D., Rapi, S., Savino, L., Massi, G., and Giordano, A. Expression of the retinoblastoma-related gene Rb2/p130 correlates with clinical outcome in endometrial cancer. J. Clin. Oncol., 16: 1085-1093, 1998.
31. Tanaka, N., Ogi, K., Odajima, T., Dehari, H., Yamada, S., Sonoda, T., and Kohama, G. pRb2/p130 protein expression is correlated with clinicopathologic findings in patients with oral squamous cell carcinoma. Cancer (Phila.), 92: 2117-2125, 2001.
32. Massaro-Giordano, M., Baldi, G., De Luca, A., Baldi, A., and Giordano, A. Differential expression of the retinoblastoma gene family members in choroidal melanoma: Prognostic significance. Clin. Cancer Res., 5: 1455-1458, 1999.
33. Leoncini, L., Bellan, C., Cossu, A., Claudio, P. P., Lazzi, S., Cinti, C., Cevenini, G., Megha, T., Laurini, L., Luzi, P., Orcioni, G. F., Piccioli, M., Pileri, S., Giardino, C., Tosi, P., and Giordano, A. Retinoblastoma-related p107 and pRb2/p130 proteins in malignant lymphomas: distinct mechanisms of cell growth control. Clin. Cancer Res., 5: 4065-4072, 1999.
34. Claudio, P. P., Howard, C. M., Fu, Y., Cinti, C., Califano, L., Micheli, P., Mercer, E. W., Caputi, M., and Giordano, A. Mutations in the retinoblastoma-related gene RB2/p130 in primary nasopharyngeal carcinoma. Cancer Res., 60: 8-12, 2000.
35. Claudio, PP., Howard, C. M., Pacilio, C., Cinti, C., Romano, G., Minimo, C., Maraldi, N. M., Minna, J. D., Gelbert, L., Leoncini, L., Tosi, G. M., Micheli, P., Caputi, M., Giordano, G. G., and Giordano, A. Mutations in the retinoblastoma-related gene RB2/p130 in lung tumors and suppression of tumor growth in vivo by retrovirus-mediated gene transfer. Cancer Res., 60: 372-382, 2000.
36. Minimo, C., Bibbo, M., Claudio, P. P., De Luca, A., and Giordano A. The role of pRb2/p130 protein in diagnosing lung carcinoma on fine needle aspiration biopsies. Pathol. Res. Pract., 195: 67-70, 1999.
37. Modi, S., Kubo, A., Oie, H., Coxon, A. B., Rehmatulla, A., and Kaye, F. J. Protein expression of the RB-related gene family and SV40 large T antigen in mesothelioma and lung cancer. Oncogene, 19: 4632-4639, 2000.
38. Del Valle, L., Baehring, J., Lorenzana, C., Giordano, A., Khalili, K., and Croul, S. Expression of a human polyomavirus oncoprotein and tumour suppressor proteins in medulloblastomas. Mol. Pathol., 54: 331-337, 2001.
39. Esposito, V., Baldi, A., De Luca, A., Groger, A. M., Loda, M., Giordano, G. G., Caputi, M., Baldi, F., Pagano, M., and Giordano, A. Prognostic role of the cyclin-dependent kinase inhibitor p27 in nonsmall cell lung cancer. Cancer Res., 57: 3381-3385, 1997.
40. Zini, N., Trimarchi, C., Claudio, P. P., Stiegler, P., Marinelli, F., Maltarello, M. C., La Sala, D., De Falco, G., Russo, G., Ammirati, G., Maraldi, N. M., Giordano, A., and Cinti, C. pRb2/p130 and p107 control cell growth by multiple strategies and in association with different compartments within the nucleus. J. Cell. Physiol., 189: 34-44, 2001.
41. Howard, C. M., Claudio, P. P., Gallia, G. L., Gordon, J., Giordano, G. G., Hauck, W. W., Khalili, K., and Giordano, A. Retinoblastomarelated protein pRb2/p130 and suppression of tumor growth in vivo. J. Natl. Cancer Inst., 90: 1451-1460, 1998.
42. Pupa, S. M., Howard, C. M., Invernizzi, A. M., De Vecchi, R., Giani, C., Claudio, P. P., Colnaghi, M. I, Giordano, A., and Menard, S. Ectopic expression of pRb2/p130 suppresses the tumorigenicity of the c-erbB-2-overexpressing SKOV3 tumor cell line. Oncogene, 18: 651-656, 1999.
43. Giordano, G. G., Muto, M., Sigalotti, L., and Maio, M. Cancer therapies: basic and clinical perspectives in brain, prostate, and lung tumors: Naples, September, 24-27, 2000. J. Cell Physiol., 188: 274-280, 2001.